LeonaBio, Inc. (LONA) › Cash & EquivalentsLeonaBio, Inc. (LONA) — Cash & EquivalentsAnnual figures by period end, from SEC filings.2019-12-31: $2.06M2020-12-31: $60.62M2021-12-31: $110.54M2022-12-31: $95.97M2023-12-31: $90.58M2024-12-31: $48.44M2025-12-31: $69.28M$69.28M2019-12-31Cash & Equivalents (USD)2025-12-31Period endedCash & EquivalentsChange YoYSource filing2025-12-31$69.28M+43.0%2026-03-31Balance as of period end2024-12-31$48.44M-46.5%2026-03-31Balance as of period end2023-12-31$90.58M-5.6%2025-02-27Balance as of period end2022-12-31$95.97M-13.2%2024-02-22Balance as of period end2021-12-31$110.54M+82.3%2023-03-23Balance as of period end2020-12-31$60.62M+2848.7%2022-03-28Balance as of period end2019-12-31$2.06M—2021-03-25Balance as of period endOther metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)